12
Participants
Start Date
April 30, 2012
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin
"Intra-arterial floxuridine:0.2 mg/KG/day for 14 days, repeated day 29. Overall 3 applications.~Systemic cisplatin: 25 mg/m2 at days 1 and 8, repeated day 22. Overall 8 applications.~Systemic gemcitabine: Three different dose levels will be tested; 600 mg/m2, 800 mg/m2, or 1000 mg/m2, at days 1 and 8, repeated day 22. Overall 8 applications."
University Hospital Zurich, Department of Oncology, Zurich
University of Zurich
OTHER